Thailand Diabetic Registry cohort: predicting death in Thai diabetic patients and causes of death

J Med Assoc Thai. 2010 Mar:93 Suppl 3:S12-20.

Abstract

Introduction: The prevalence of type 2 diabetes in Thailand is 9.8 percent which is double the number forecast by World Health Organization. There is inadequate information to statistically represent all Thai diabetic patients for their causes of death.

Objective: To determine the clinical characteristics that predicted death and causes of death in Thai diabetic patients.

Material and method: This prospective cohort was a 3-year follow-up study of the Thai Diabetes Registry project done between April, 2003, and February, 2006, which registered 9,419 diabetic patients attending 11 diabetic clinics in tertiary medical centers in Bangkok and major provinces of Thailand. The dead or alive status (99.5%) was determined. The causes of death were defined by reviewing the medical records.

Results: Of the 9,370 diabetic patients registered, 425 patients died, 1.84 percent per year. There was an increased risk of death associated with age, type of healthcare plan, lower education, insulin use, smoking, history of coronary artery disease and cerebrovascular disease, serum creatinine and high HbA1c. Lipid-lowering medication and metformin decreased the risk of death. Cardiovascular disease, infection and cancer were the prevalent causes of death.

Conclusion: The present study showed risk factors that influenced death and causes of death in Thai diabetics.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Asian People
  • Cardiovascular Diseases / complications
  • Cardiovascular Diseases / mortality*
  • Cause of Death*
  • Diabetes Complications / mortality*
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / mortality*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Dyslipidemias / drug therapy
  • Dyslipidemias / epidemiology*
  • Female
  • Follow-Up Studies
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Hypolipidemic Agents / therapeutic use
  • Infections / etiology
  • Infections / mortality
  • Male
  • Metformin / therapeutic use
  • Middle Aged
  • Neoplasms / etiology
  • Neoplasms / mortality
  • Prevalence
  • Prospective Studies
  • Registries
  • Risk Factors
  • Thailand / epidemiology

Substances

  • Hypoglycemic Agents
  • Hypolipidemic Agents
  • Metformin